Pricing
Login
Home
Charts
Search
Watchlist
Products

Divis Laboratories Ltd

DIVISLAB
₹11,180.50+0.02%20 Nov 2026
Reports
Pharma CRAMS

Divis Laboratories Ltd

DIVISLAB
₹11,180.50
+0.02%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹2,96,807Cr
Close
Close Price
₹11,180.50
Industry
Industry
Pharma CRAMS
PE
Price To Earnings
88.22
PS
Price To Sales
24.35
Revenue
Revenue
₹12,191Cr
Rev Gr TTM
Revenue Growth TTM
21.56%
PAT Gr TTM
PAT Growth TTM
35.33%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1,8552,3032,1182,3382,3192,5852,4102,7152,6042,8313,0803,676
Growth YoY
Revenue Growth YoY%
8.618.019.122.525.012.213.816.112.39.527.835.4
Expenses
ExpensesCr
1,3661,5721,4961,6221,5761,6991,6811,8271,7141,8971,8252,110
Operating Profit
Operating ProfitCr
4897316227167438867298888909341,2551,566
OPM
OPM%
26.431.729.430.632.034.330.332.734.233.040.842.6
Other Income
Other IncomeCr
9579791068286119145141556494
Interest Expense
Interest ExpenseCr
0201013866613
Depreciation
DepreciationCr
9595979999107112113118120133142
PBT
PBTCr
4897136047227268647339127809631,1801,505
Tax
TaxCr
131175174212137202188223197212278378
PAT
PATCr
3585384305105896625456895837519021,127
Growth YoY
PAT Growth YoY%
17.067.620.846.564.523.126.735.1-1.013.465.563.6
NPM
NPM%
19.323.420.321.825.425.622.625.422.426.529.330.7
EPS
EPS₹
13.520.316.219.222.224.920.526.022.028.334.042.5
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1,8552,3032,1182,3382,3192,5852,4102,7152,6042,8313,0803,676
Growth YoY
Revenue Growth YoY%
8.618.019.122.525.012.213.816.112.39.527.835.4
Expenses
ExpensesCr
1,3661,5721,4961,6221,5761,6991,6811,8271,7141,8971,8252,110
Operating Profit
Operating ProfitCr
4897316227167438867298888909341,2551,566
OPM
OPM%
26.431.729.430.632.034.330.332.734.233.040.842.6
Other Income
Other IncomeCr
9579791068286119145141556494
Interest Expense
Interest ExpenseCr
0201013866613
Depreciation
DepreciationCr
9595979999107112113118120133142
PBT
PBTCr
4897136047227268647339127809631,1801,505
Tax
TaxCr
131175174212137202188223197212278378
PAT
PATCr
3585384305105896625456895837519021,127
Growth YoY
PAT Growth YoY%
17.067.620.846.564.523.126.735.1-1.013.465.563.6
NPM
NPM%
19.323.420.321.825.425.622.625.422.426.529.330.7
EPS
EPS₹
13.520.316.219.222.224.920.526.022.028.334.042.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3,7764,0643,8914,9465,3946,9698,9607,7687,8459,36010,56012,191
Growth
Revenue Growth%
21.27.6-4.327.19.129.228.6-13.31.019.312.821.6
Expenses
ExpensesCr
2,3592,6182,6303,0743,5724,1095,0785,4005,6406,3927,1197,546
Operating Profit
Operating ProfitCr
1,4171,4461,2621,8721,8222,8603,8822,3682,2052,9683,4414,645
OPM
OPM%
37.535.632.437.833.841.043.330.528.131.732.638.1
Other Income
Other IncomeCr
977511315619063114345339352433327
Interest Expense
Interest ExpenseCr
42146111322331
Depreciation
DepreciationCr
118123142169186256312343378402463513
PBT
PBTCr
1,3931,3951,2311,8551,8192,6663,6842,3692,1632,9163,3884,428
Tax
TaxCr
2673353545024436827235455637258201,065
PAT
PATCr
1,1261,0608771,3531,3771,9842,9601,8231,6002,1912,5683,363
Growth
PAT Growth%
32.2-5.8-17.354.21.844.149.2-38.4-12.336.917.235.3
NPM
NPM%
29.826.122.527.425.528.533.023.520.423.424.327.6
EPS
EPS₹
42.440.033.051.051.974.8111.568.760.382.596.8126.7
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3,7764,0643,8914,9465,3946,9698,9607,7687,8459,36010,56012,191
Growth
Revenue Growth%
21.27.6-4.327.19.129.228.6-13.31.019.312.821.6
Expenses
ExpensesCr
2,3592,6182,6303,0743,5724,1095,0785,4005,6406,3927,1197,546
Operating Profit
Operating ProfitCr
1,4171,4461,2621,8721,8222,8603,8822,3682,2052,9683,4414,645
OPM
OPM%
37.535.632.437.833.841.043.330.528.131.732.638.1
Other Income
Other IncomeCr
977511315619063114345339352433327
Interest Expense
Interest ExpenseCr
42146111322331
Depreciation
DepreciationCr
118123142169186256312343378402463513
PBT
PBTCr
1,3931,3951,2311,8551,8192,6663,6842,3692,1632,9163,3884,428
Tax
TaxCr
2673353545024436827235455637258201,065
PAT
PATCr
1,1261,0608771,3531,3771,9842,9601,8231,6002,1912,5683,363
Growth
PAT Growth%
32.2-5.8-17.354.21.844.149.2-38.4-12.336.917.235.3
NPM
NPM%
29.826.122.527.425.528.533.023.520.423.424.327.6
EPS
EPS₹
42.440.033.051.051.974.8111.568.760.382.596.8126.7
Sales CAGR
1 Year13%
3 Years11%
5 Years9%
TTM22%
EBITDA CAGR
1 Year16%
3 Years13%
5 Years4%
TTM43%
PAT CAGR
1 Year17%
3 Years12%
5 Years5%
TTM35%
Avg. ROCE
1 Year20%
3 Years19%
5 Years21%
TTM25%
CFO / EBITDA
1 Year80%
3 Years66%
5 Years67%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
535353535353535353535353
Reserves
ReservesCr
4,2405,3045,8726,9047,2579,24211,67512,71413,51814,91616,70817,944
Current Liabilities
Current LiabilitiesCr
5206596538479271,1121,1961,1011,2781,4522,0432,707
Non Current Liabilities
Non Current LiabilitiesCr
891422082342993674515716215111,2291,260
Total Liabilities
Total LiabilitiesCr
4,9026,1596,7868,0388,53610,77413,37514,43915,47016,93220,03321,964
Current Assets
Current AssetsCr
3,0274,0114,5354,6504,6806,1758,3529,3129,67510,08111,09612,439
Non Current Assets
Non Current AssetsCr
1,8752,1482,2513,3883,8564,5995,0235,1275,7956,8518,9379,525
Total Assets
Total AssetsCr
4,9026,1596,7868,0388,53610,77413,37514,43915,47016,93220,03321,964
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
535353535353535353535353
Reserves
ReservesCr
4,2405,3045,8726,9047,2579,24211,67512,71413,51814,91616,70817,944
Current Liabilities
Current LiabilitiesCr
5206596538479271,1121,1961,1011,2781,4522,0432,707
Non Current Liabilities
Non Current LiabilitiesCr
891422082342993674515716215111,2291,260
Total Liabilities
Total LiabilitiesCr
4,9026,1596,7868,0388,53610,77413,37514,43915,47016,93220,03321,964
Current Assets
Current AssetsCr
3,0274,0114,5354,6504,6806,1758,3529,3129,67510,08111,09612,439
Non Current Assets
Non Current AssetsCr
1,8752,1482,2513,3883,8564,5995,0235,1275,7956,8518,9379,525
Total Assets
Total AssetsCr
4,9026,1596,7868,0388,53610,77413,37514,43915,47016,93220,03321,964

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1,0381,1507769541,2161,9471,9122,4601,2611,6532,738
Investing Cash Flow
Investing Cash FlowCr
-406-1,140-478-685-8375-2,195-2,708-269-804-2,219
Financing Cash Flow
Financing Cash FlowCr
-6312-314-246-1,091-35-532-797-799-799-804
Net Cash Flow
Net Cash FlowCr
013-1723411,987-816-1,04519350-285
Free Cash Flow
Free Cash FlowCr
642774502221331,0371,1991,987258215221
CFO To PAT
CFO To PAT%
92.2108.588.570.588.398.164.6134.978.875.5106.6
CFO To EBITDA
CFO To EBITDA%
73.279.561.551.066.768.149.3103.957.255.779.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1,0381,1507769541,2161,9471,9122,4601,2611,6532,738
Investing Cash Flow
Investing Cash FlowCr
-406-1,140-478-685-8375-2,195-2,708-269-804-2,219
Financing Cash Flow
Financing Cash FlowCr
-6312-314-246-1,091-35-532-797-799-799-804
Net Cash Flow
Net Cash FlowCr
013-1723411,987-816-1,04519350-285
Free Cash Flow
Free Cash FlowCr
642774502221331,0371,1991,987258215221
CFO To PAT
CFO To PAT%
92.2108.588.570.588.398.164.6134.978.875.5106.6
CFO To EBITDA
CFO To EBITDA%
73.279.561.551.066.768.149.3103.957.255.779.6

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
26,15016,56928,92345,21552,76396,3661,16,90875,01591,2351,53,2581,57,8622,96,807
Price To Earnings
Price To Earnings
23.215.633.033.438.348.639.541.156.969.861.488.2
Price To Sales
Price To Sales
6.94.17.49.19.813.813.19.711.616.414.924.4
Price To Book
Price To Book
6.13.14.96.57.210.410.05.96.710.29.416.5
EV To EBITDA
EV To EBITDA
18.411.422.924.128.932.929.429.939.650.444.963.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
52.053.650.354.051.458.258.749.648.351.152.152.1
OPM
OPM%
37.535.632.437.833.841.043.330.528.131.732.638.1
NPM
NPM%
29.826.122.527.425.528.533.023.520.423.424.327.6
ROCE
ROCE%
32.225.920.626.324.828.731.418.616.019.520.324.8
ROE
ROE%
26.219.814.819.418.821.425.214.311.814.615.318.7
ROA
ROA%
23.017.212.916.816.118.422.112.610.312.912.815.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
26,15016,56928,92345,21552,76396,3661,16,90875,01591,2351,53,2581,57,8622,96,807
Price To Earnings
Price To Earnings
23.215.633.033.438.348.639.541.156.969.861.488.2
Price To Sales
Price To Sales
6.94.17.49.19.813.813.19.711.616.414.924.4
Price To Book
Price To Book
6.13.14.96.57.210.410.05.96.710.29.416.5
EV To EBITDA
EV To EBITDA
18.411.422.924.128.932.929.429.939.650.444.963.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
52.053.650.354.051.458.258.749.648.351.152.152.1
OPM
OPM%
37.535.632.437.833.841.043.330.528.131.732.638.1
NPM
NPM%
29.826.122.527.425.528.533.023.520.423.424.327.6
ROCE
ROCE%
32.225.920.626.324.828.731.418.616.019.520.324.8
ROE
ROE%
26.219.814.819.418.821.425.214.311.814.615.318.7
ROA
ROA%
23.017.212.916.816.118.422.112.610.312.912.815.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr2,96,8071,23,98053,58938,27931,85931,38526,483
Close PriceClose₹11,180.502,294.60951.051,800.70239.303,833.5020,642.00
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE88.2292.4587.17101.2271.4758.52
Price To SalesPS24.3515.8526.1916.143.2619.7111.48
RevenueRevenueCr12,1917,8232,0462,3719,7791,5932,307
Revenue Growth TTMRev Gr TTM%21.6%23.0%-1.2%15.5%9.4%45.2%50.5%
PAT Growth TTMPAT Gr TTM%35.3%96.3%18.9%31.4%-782.0%95.8%88.4%
Market CapitalizationMkt CapCr2,96,8071,23,98053,58938,27931,85931,38526,483
Close PriceClose₹11,180.502,294.60951.051,800.70239.303,833.5020,642.00
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE88.2292.4587.17101.2271.4758.52
Price To SalesPS24.3515.8526.1916.143.2619.7111.48
RevenueRevenueCr12,1917,8232,0462,3719,7791,5932,307
Revenue Growth TTMRev Gr TTM%21.6%23.0%-1.2%15.5%9.4%45.2%50.5%
PAT Growth TTMPAT Gr TTM%35.3%96.3%18.9%31.4%-782.0%95.8%88.4%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Annual Reports
Quarterly Reports
Load More
Interviews